Antibody-mediated rejection in liver transplantation: Current controversies and future directions

Timucin Taner, Mark D. Stegall, Julie K. Heimbach

Research output: Contribution to journalReview article

30 Scopus citations


Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.

Original languageEnglish (US)
Pages (from-to)514-527
Number of pages14
JournalLiver Transplantation
Issue number5
StatePublished - May 2014


ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Cite this